glucose, (beta-d)-isomer and Experimental Neoplasms
glucose, (beta-d)-isomer has been researched along with Experimental Neoplasms in 61 studies
Research
Studies (61)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 35 (57.38) | 18.7374 |
1990's | 7 (11.48) | 18.2507 |
2000's | 5 (8.20) | 29.6817 |
2010's | 12 (19.67) | 24.3611 |
2020's | 2 (3.28) | 2.80 |
Authors
Authors | Studies |
---|---|
Cheng, J; Hakamatsuka, Y; Nagata, T; Naito, Y; Ohara, N; Okimoto, M; Tachibana, S | 1 |
Cai, DL; Lin, N; Liu, XL; Yuan, JJ; Zan, D | 1 |
JUDE, JR; SCHATTEN, WE | 1 |
BERTOYE, A; VIALLIER, J | 1 |
BERNDT, H; HEISE, E; LUHRS, W | 1 |
NAGY, I; PUTNOKY, G | 1 |
KOSSEY, P; ORAVEC, C; SMIDOVA-KOVAROVA, V | 2 |
BIRD, L; ENOMOTO, K; FUJISAWA, M; MILLER, C; SAELHOF, CC; SOKOLOFF, B; TODA, Y | 1 |
ISHIBASHI, Y | 1 |
KOSZORU, M; MAJOROSSY, K; NAGY, I; VAJDA, J | 1 |
FUJII, K; SATO, H; SATOH, H | 1 |
OMORI, Y | 1 |
MARTIN, DS | 1 |
MCCONNELL, B; SOKOLOFF, B | 1 |
PESKOVA, D; PETAKOVA, M; RERABKOVA, E; RYBAK, M | 1 |
Bova, FJ; Mariani, CL; Rajon, D; Streit, WJ | 1 |
Glaves, D | 1 |
Ato, M; Dondog, EA; Hatakeyama, S; Ishikura, H; Iwabuchi, C; Iwabuchi, K; Kato, M; Matsuki, N; Matsushima, K; Mukaida, N; Negishi, I; Nishihori, H; Ogasawara, K; Onoé, K; Takahashi, A; Takayanagi, T; Watano, K | 1 |
Nikulina, LB | 1 |
Nakoinz, I; Ralph, P | 1 |
Currie, GA | 1 |
Levy, PC; LoBuglio, AF; Shaw, GM | 1 |
Jasková, J; Rejthar, A; Rejtharová, A; Wotke, J | 1 |
Kalafut, F; Klobusická, M; Kusenda, J; Novotná, L | 1 |
Aronsson, EF; Gretarsdottir, J; Hafström, L; Holmberg, SB; Jacobsson, L; Lindholm, L; Mattsson, S | 1 |
Altom, MG; Nanda, SK; Schultz, RM | 1 |
Herriott, MJ; Leu, RW | 1 |
Mørland, B | 1 |
Hartveit, F; Horseide, V; Thunold, S | 1 |
Endo, S; Shinoki, T | 1 |
Fukushima, M; Horimai, T; Ishikawa, Y; Komaba, M; Sato, T | 1 |
Kampschmidt, RF; Upchurch, HF | 1 |
Pfordte, K | 2 |
Hänsel, H; Heber, J | 1 |
Veksler, IG | 1 |
Balitskiĭ, KP; Struk, VI | 1 |
Matthies, E; Pfordte, K | 1 |
Albershardt, TC; Berglund, P; James, R; Krull, J; Leleux, JA; Parsons, AJ; Reeves, R; Ter Meulen, J | 1 |
Dai, Y; Hong, YS; Li, B; Li, HM; Li, Y; Ma, H; Ma, T; Sun, X; Wu, CZ; Zhu, M | 1 |
Lin, Y; Liu, L; Qiu, F; Yang, Z | 1 |
Choi, JS; Jeong, JW; Kim, JE; Kim, KH; Kong, CS; Park, C | 1 |
Akashi, H; Hamano, S; Hayashi, N; Joh, T; Kataoka, H; Kubota, E; Mori, Y; Moriwaki, K; Ohi, H; Taguchi, T; Tanaka, M; Tanida, S; Yano, S | 1 |
Duan, L; Jiang, C; Li, B; Liu, B; Wu, H; Xu, J; Yuan, Y; Zeng, X; Zhang, G; Zhang, Y; Zhao, X | 1 |
Ben-Eliyahu, S; Benbenishty, A; Elbaz, E; Gotlieb, N; Lavon, H; Matzner, P; Melamed, R; Reed, SG; Rosenne, E; Shaashua, L; Sorski, L | 1 |
Kuttan, G; Murali, VP | 1 |
Chen, Y; Gong, X; Liu, F; Xue, G | 1 |
Gan, M; Jiang, T; Xiao, R | 1 |
Kim, YH; Lee, KM; Sonn, CH; Won, YW; Yoon, SM | 1 |
Awasthi, S; Fast, S; Nagaprashantha, LD; Roby, R; Singhal, J; Singhal, SS; Vatsyayan, R | 1 |
Chen, PN; Chiang, CL; Chiou, HL; Chu, SC; Hsieh, YS; Kuo, WH | 1 |
Beck, R; Haubner, R; Johnson, TD; Machulla, HJ; Picchio, M; Piert, M; Reischl, G; Schwaiger, M; Seidl, S; Wester, HJ | 1 |
Arakawa, H; Iguchi, T; Kojiri, K; Morita, M; Nishimura, S; Okura, A; Suda, H; Yoshinari, T | 1 |
Arakawa, H; Iguchi, T; Kojiri, K; Okura, A; Suda, H; Yoshinari, T | 1 |
Matsui, H; Shoda, T; Takada, K; Takahashi, M; Toyoda, K; Uneyama, C | 1 |
Saijo, N | 1 |
Arakawa, H; Kawamoto, H; Kojiri, K; Kondo, H; Morishima, H; Nishimura, I; Nishimura, S; Nishimura, T; Ohkubo, M; Suda, H; Tanaka, S; Yoshinari, T | 1 |
Furukawa, F; Hirose, M; Ikeda, T; Imazawa, T; Kasahara, K; Nishikawa, A; Takahashi, M | 1 |
Cudlín, J; Hilgert, I; Steinerová, N; Vanĕk, Z | 1 |
Chengjiany, B; Eryi, X; Haodong, S; Reiming, S; Xili, L; Yuengming, W; Zhiyian, H | 1 |
Reviews
1 review(s) available for glucose, (beta-d)-isomer and Experimental Neoplasms
Article | Year |
---|---|
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Glucosides; Humans; Irinotecan; Japan; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasms, Experimental; Paclitaxel; Purine Nucleosides; Staurosporine; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 1998 |
Other Studies
60 other study(ies) available for glucose, (beta-d)-isomer and Experimental Neoplasms
Article | Year |
---|---|
Locally applied TCP inhibits tumor growth via possible activation of macrophages.
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Calcium Phosphates; Cell Line, Tumor; Humans; Luminescence; Luminol; Macrophage Activation; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Neutrophils; Opsonin Proteins; Phagocytosis; Zymosan | 2010 |
Effect of zymosan on antioxidant and immune function of S180 tumor-bearing mice.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cyclophosphamide; Glutathione Peroxidase; Interleukin-2; Liver; Male; Malondialdehyde; Mice; Neoplasms, Experimental; Superoxide Dismutase; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Zymosan | 2011 |
The ineffectiveness of zymosan in altering the heterotransplantation of tumors to rats.
Topics: Animals; Neoplasms; Neoplasms, Experimental; Polysaccharides; Rats; Yeasts; Zymosan | 1958 |
[Effects of zymosan injections on the evolution of transplanted experimental cancers].
Topics: Animals; Injections; Neoplasms, Experimental; Polysaccharides; Yeasts; Zymosan | 1958 |
[Effects of zymosan on tumor growth in experimental animals].
Topics: Animals; Neoplasms; Neoplasms, Experimental; Polysaccharides; Yeasts; Zymosan | 1958 |
[Inhibiting effect of zymosan on transplanted tumor growth in mice].
Topics: Animals; Mice; Neoplasms; Neoplasms, Experimental; Polysaccharides; Zymosan | 1960 |
[Hetero-transplantation of Walker 256 carcinoma in hamsters previously treated with cortisone, antiserum and zymosan].
Topics: Animals; Cortisone; Cricetinae; Immune Sera; Neoplasms, Experimental; Polysaccharides; Zymosan | 1960 |
Experimental studies on Mitomycin C. 4. Zymosan and the R. E. S.
Topics: Animals; Mitomycin; Mononuclear Phagocyte System; Neoplasms, Experimental; Zymosan | 1961 |
RETICULOENDOTHELIAL SYSTEM AND NEOPLASMA.
Topics: Animals; Antibodies; Bacteriophages; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Colonic Neoplasms; Lung Neoplasms; Mice; Mononuclear Phagocyte System; Neoplasms; Neoplasms, Experimental; Pancreatic Neoplasms; Properdin; Rectal Neoplasms; Research; Skin Transplantation; Stomach Neoplasms; Tetanus Toxoid; Tuberculin Test; Zymosan | 1964 |
[PREVENTION OF THE CONSEQUENCES OF TUMOR CELL DISSEMINATION IN BROWN-PEARCE TESTICULAR TUMOR IN RABBITS BY ADMINISTRATION OF MANNOZYM].
Topics: Animals; Antineoplastic Agents; Carcinoma, Brown-Pearce; Humans; Immune Sera; Male; Mannans; Neoplasms; Neoplasms, Experimental; Rabbits; Research; Testicular Neoplasms; Zymosan | 1964 |
ACQUIRED RESISTANCE AGAINST THE GROWTH OF YOSHIDA SARCOMA CELLS IN DONRYU RATS.
Topics: Animals; Carcinoma, Hepatocellular; Ink; Leukemia; Leukemia, Experimental; Liver Neoplasms; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mycobacterium bovis; Neoplasms; Neoplasms, Experimental; Pharmacology; Rats; Research; Sarcoma; Sarcoma, Yoshida; Transplantation; Trypan Blue; Typhoid-Paratyphoid Vaccines; Zymosan | 1964 |
THE RELATION BETWEEN THE RETICULOENDOTHELIAL SYSTEM AND THE SPREAD OF CANCER, ESPECIALLY OF GASTRIC CARCINOMA.
Topics: Animals; Carcinoma 256, Walker; Genetic Diseases, X-Linked; Leukemia, Hairy Cell; Lymphatic Diseases; Lymphatic Metastasis; Mononuclear Phagocyte System; Neoplasms; Neoplasms, Experimental; Phagocytosis; Pharmacology; Rats; Research; Severe Combined Immunodeficiency; Stomach Neoplasms; Zymosan | 1964 |
CHEMOTHERAPEUTIC CURE OF SPONTANEOUS MOUSE CANCER.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cortisone; Humans; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mercaptopurine; Mice; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds; Pharmacology; Puromycin; Research; Sarcoma 180; Uracil Mustard; Zymosan | 1964 |
HOST DEFENCE AND CHEMOTHERAPY IN EXPERIMENTAL CANCER.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Dactinomycin; Flavonoids; Lymphoma; Lymphoma, Non-Hodgkin; Mice; Mitomycin; Mitomycins; Mononuclear Phagocyte System; Neoplasms; Neoplasms, Experimental; Pharmacology; Polysaccharides; Rabbits; Research; Sarcoma 180; Trypan Blue; Zymosan | 1964 |
THE INFLUENCE OF ISOLATED PROPERDIN ON HELA-AND DETROIT 6-CELLS IN VITRO.
Topics: Animals; Antineoplastic Agents; Cattle; HeLa Cells; Humans; Immune Sera; In Vitro Techniques; Neoplasms, Experimental; Pharmacology; Properdin; Rabbits; Research; Tissue Culture Techniques; Zymosan | 1964 |
Heterotransplantation of tumours--Part II. Heterotransplantation of Walker 256 carcinoma in hamster treated with cortisone, antigen, antiserum and zymosan.
Topics: Animals; Antigens; Cortisone; Cricetinae; Immune Sera; Neoplasms; Neoplasms, Experimental; Polysaccharides; Zymosan | 1959 |
Nonspecific immunotherapy with intratumoral lipopolysaccharide and zymosan A but not GM-CSF leads to an effective anti-tumor response in subcutaneous RG-2 gliomas.
Topics: Adjuvants, Immunologic; Animals; Brain Neoplasms; Combined Modality Therapy; Dendritic Cells; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Screening Assays, Antitumor; Female; Glioma; Granulocyte-Macrophage Colony-Stimulating Factor; Immunotherapy; Injections, Intralesional; Injections, Subcutaneous; Lipopolysaccharides; Macrophages; Male; Neoplasms, Experimental; Rats; Rats, Inbred F344; Rats, Nude; Subcutaneous Tissue; Survival Analysis; Treatment Outcome; Zymosan | 2007 |
Metastasis: reticuloendothelial system and organ retention of disseminated malignant cells.
Topics: Animals; Endotoxins; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Mice; Mononuclear Phagocyte System; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Time Factors; Zymosan | 1980 |
Delayed clearance of zymosan-induced granuloma and depressed phagocytosis of macrophages with concomitant up-regulated kinase activities of Src-family in a human monocyte chemoattractant protein-1 transgenic mouse.
Topics: Animals; Ascitic Fluid; Chemokine CCL2; Granuloma; Humans; Lymphoid Tissue; Macrophages, Peritoneal; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Neoplasms, Experimental; Nitric Oxide; Phagocytosis; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-hck; src-Family Kinases; Up-Regulation; Zymosan | 2000 |
[Effect of actinomycin D, carminomycin and bleomycin and their joint use with serotonin and zymosan on the functional state of the peritoneal macrophages].
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Carubicin; Dactinomycin; Drug Combinations; Female; Macrophages; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Neoplasms, Experimental; Peritoneal Cavity; Phagocytosis; Serotonin; Time Factors; Uterine Cervical Neoplasms; Zymosan | 1978 |
Direct toxic effects of immunopotentiators on monocytic, myelomonocytic, and histiocytic or macrophage tumor cells in culture.
Topics: Adjuvants, Immunologic; BCG Vaccine; Cell Division; Cell Survival; Cells, Cultured; Dextrans; Latex; Leukemia, Myeloid; Lipopolysaccharides; Lymphocyte Activation; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Microspheres; Monocytes; Muramidase; Mycobacterium bovis; Neoplasms, Experimental; Tuberculin; Zymosan | 1977 |
Activated macrophages kill tumour cells by releasing arginase.
Topics: Animals; Arginase; Arginine; Ascitic Fluid; Cell Line; Cytotoxins; Female; Lipopolysaccharides; Macrophages; Mice; Neoplasms, Experimental; Zymosan | 1978 |
Human monocyte antibody-dependent cell-mediated cytotoxicity to tumor cells.
Topics: Antibody-Dependent Cell Cytotoxicity; Cell Line; Cell Survival; DNA, Neoplasm; Humans; Lymphocytes; Monocytes; Neoplasms, Experimental; Zymosan | 1978 |
Nonspecific resistance to tumor allograft.
Topics: Adenocarcinoma; Animals; BCG Vaccine; Immunosuppression Therapy; Immunotherapy; Lymphocytes; Macrophages; Mice; Mice, Inbred Strains; Mycobacterium bovis; Neoplasm Transplantation; Neoplasms, Experimental; Spleen; Transplantation Immunology; Transplantation, Homologous; Zymosan | 1975 |
Tumoricidal properties of rat peritoneal macrophages activated with various activators depend on nitrogen oxid synthesis.
Topics: Animals; Arginine; Cells, Cultured; Chromium Radioisotopes; Culture Media; Female; Immunotherapy; Interferon-gamma; Interleukin-2; Lipopolysaccharides; Macrophage Activation; Macrophages; Neoplasms, Experimental; Nitrites; Peritoneal Cavity; Rats; Rats, Inbred Lew; Recombinant Proteins; Tetradecanoylphorbol Acetate; Zymosan | 1992 |
Kinetics of radioiodinated monoclonal antibodies in the rat. Influence of tumour growth and reticuloendothelial system host modulation.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Colonic Neoplasms; Female; Humans; Iodine Radioisotopes; Liver; Male; Mononuclear Phagocyte System; Neoplasms, Experimental; Rats; Rats, Inbred Strains; Zymosan | 1989 |
Effects of various inhibitors of arachidonic acid oxygenation on macrophage superoxide release and tumoricidal activity.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Auranofin; Aurothioglucose; Cells, Cultured; Cyclooxygenase Inhibitors; Cytotoxicity, Immunologic; Lipoxygenase Inhibitors; Lymphokines; Macrophage Activation; Macrophage-Activating Factors; Macrophages; Male; Mice; Neoplasms, Experimental; Phagocytosis; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1985 |
Triggering of interferon gamma-primed macrophages by various known complement activators for nonspecific tumor cytotoxicity.
Topics: Animals; Complement Activation; Cytotoxicity, Immunologic; Elapid Venoms; In Vitro Techniques; Interferon-gamma; Lipid A; Lipopolysaccharides; Macrophage Activation; Male; Mice; Neoplasms, Experimental; Poly I-C; Receptors, Fc; Zymosan | 1987 |
Cytotoxic activity of stimulated mouse macrophages exposed to various inhibitors.
Topics: Animals; Carbon Radioisotopes; Cell Line; Chloroquine; Colchicine; Cytotoxicity, Immunologic; Lysosomes; Macrophage Activation; Macrophages; Mice; Mice, Inbred Strains; Monensin; Neoplasms, Experimental; Peritoneal Cavity; Zymosan | 1986 |
Complement factors and the growth of Ehrlich's carcinoma.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Transformation, Neoplastic; Complement Inactivator Proteins; Complement System Proteins; gamma-Globulins; Hot Temperature; Humans; Immune Sera; Immunodiffusion; Immunoelectrophoresis; Immunoglobulin G; Leukocytes; Male; Methods; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Rabbits; Time Factors; Transplantation, Homologous; Zymosan | 1973 |
Influence of reticuloendothelial function on the growth of transplantable rat ascites hepatoma (AH-130).
Topics: Animals; Carcinoma, Hepatocellular; Coloring Agents; Histiocytes; In Vitro Techniques; Injections, Intraperitoneal; Liver Neoplasms; Microscopy, Electron; Mononuclear Phagocyte System; Neoplasm Transplantation; Neoplasms, Experimental; Peritoneal Cavity; Phagocytosis; Povidone; Rats; Zymosan | 1968 |
[Factors influencing the effects of the antineoplastic action of antineoplastic agents. 3. Combined effects of mitomycin C and zymosan on tumors in rats].
Topics: Animals; Carcinoma, Hepatocellular; Liver Neoplasms; Male; Mitomycins; Neoplasms, Experimental; Rats; Zymosan | 1968 |
Stimulation of the reticuloendothelial system in tumor-bearing rats.
Topics: Animals; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Diethylstilbestrol; Endotoxins; Female; Liver Neoplasms; Mononuclear Phagocyte System; Neoplasms, Experimental; Rats; Sarcoma, Experimental; Triolein; Zymosan | 1968 |
[Studies on properdin].
Topics: Animals; Antineoplastic Agents; Body Fluids; Desoxycorticosterone; Immunity; Mice; Neoplasms, Experimental; Properdin; Rats; Zymosan | 1966 |
[Influence of resactin "Dessau" on the survival time of animals bearing nonspecific transplantation tumors (author's transl)].
Topics: Animals; Antibiotics, Antineoplastic; Cyclohexanes; Dose-Response Relationship, Drug; Female; Mathematics; Mononuclear Phagocyte System; Neoplasm Transplantation; Neoplasms, Experimental; Piperidones; Rats; Sarcoma, Yoshida; Time Factors; Zymosan | 1974 |
[The effect of zymosan on the toxicity and activity of various antitumor preparations].
Topics: Animals; Antineoplastic Agents; Injections, Intravenous; Injections, Subcutaneous; Melphalan; Neoplasm Transplantation; Neoplasms, Experimental; Rabbits; Rats; Thiotepa; Zymosan | 1966 |
[Relations between properdin and tumor resistance].
Topics: Animals; Female; Magnesium Oxide; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Properdin; Rats; Ultraviolet Therapy; Zymosan | 1970 |
[Activation of protective reactions of the organism in malignant growths].
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Benzimidazoles; Drug Synergism; Immunity, Active; Neoplasms, Experimental; Parasympatholytics; Pigments, Biological; Prodigiosin; Pyrroles; Rabbits; Rats; Zymosan | 1968 |
[Tumor resistance and properdin level].
Topics: Animals; Carcinoma 256, Walker; Neoplasms, Experimental; Properdin; Rats; Sarcoma, Experimental; Sarcoma, Yoshida; Stimulation, Chemical; Zymosan | 1966 |
Intratumoral expression of IL-12 from lentiviral or RNA vectors acts synergistically with TLR4 agonist (GLA) to generate anti-tumor immunological memory.
Topics: Animals; CD8-Positive T-Lymphocytes; Female; Gene Expression Regulation; Genetic Vectors; Glucosides; Immunity, Innate; Immunologic Memory; Immunotherapy; Interferon-gamma; Interleukin-12; Lentivirus; Lipid A; Melanoma, Experimental; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Neoplasms, Experimental; Toll-Like Receptor 4 | 2021 |
Enzymatic biosynthesis and biological evaluation of novel 17-AAG glucoside as potential anti-cancer agents.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glucosides; Glycosylation; Glycosyltransferases; Humans; Lactams, Macrocyclic; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship; Uridine Diphosphate | 2020 |
Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Count; Cell Proliferation; Cells, Cultured; DNA Damage; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Glucosides; Humans; Hydrolyzable Tannins; Male; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Protein Kinase Inhibitors; Structure-Activity Relationship; Ubiquitin-Protein Ligases | 2019 |
Salicin, an extract from white willow bark, inhibits angiogenesis by blocking the ROS-ERK pathways.
Topics: Angiogenesis Inhibitors; Animals; Aorta; Benzyl Alcohols; Cell Line, Tumor; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Plant Bark; Rats, Sprague-Dawley; Reactive Oxygen Species; Salix | 2014 |
Antitumor effects in gastrointestinal stromal tumors using photodynamic therapy with a novel glucose-conjugated chlorin.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gene Expression Regulation, Neoplastic; Glucosides; Glycoconjugates; Humans; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Porphyrins; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2014 |
Anti-tumor activity of verbascoside loaded gold nanoparticles.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Diffusion; Female; Glucosides; Gold; Humans; K562 Cells; Metal Nanoparticles; Mice; Mice, Nude; Nanocapsules; Neoplasms, Experimental; Particle Size; Phenols; Treatment Outcome | 2014 |
Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effects.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Line, Tumor; Female; Flow Cytometry; Glucosides; Lipid A; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasms, Experimental; Perioperative Period; Rats; Rats, Inbred F344; Toll-Like Receptor 4 | 2016 |
Curculigoside augments cell-mediated immune responses in metastatic tumor-bearing animals.
Topics: Animals; Benzoates; Curculigo; Cytokines; Glucosides; Heterografts; Humans; Immunity, Cellular; K562 Cells; Male; Mice; Neoplasm Metastasis; Neoplasms, Experimental | 2016 |
Immunosuppressive effect of extracts from leaves of Fraxinus Mandshurica Rupr.
Topics: Animals; Caffeic Acids; Cell Line; Cytokines; Dose-Response Relationship, Drug; Fraxinus; Glucosides; Humans; Immunosuppressive Agents; Mice; Neoplasms, Experimental; Plant Extracts; Plant Leaves; Species Specificity; Spleen | 2017 |
Wogonoside exerts growth-suppressive effects against T acute lymphoblastic leukemia through the STAT3 pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Flavanones; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Male; Mice; Mice, Nude; Neoplasms, Experimental; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; STAT3 Transcription Factor | 2017 |
Nano self-assembly of recombinant human gelatin conjugated with α-tocopheryl succinate for Hsp90 inhibitor, 17-AAG, delivery.
Topics: alpha-Tocopherol; Animals; Gelatin; Glucosides; HSP90 Heat-Shock Proteins; Humans; Mice; Nanocapsules; Neoplasms, Experimental; Recombinant Proteins; Terpenes | 2011 |
Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Aorta; Apigenin; Apoptosis; Cell Line; Cell Movement; Docetaxel; Drug Synergism; Drug Therapy, Combination; Glucosides; Male; Mice; Mice, Nude; Neoplasms, Experimental; Prostatic Neoplasms; Taxoids; Time Factors; Tissue Culture Techniques | 2011 |
Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and u-PA expression.
Topics: Animals; Anthocyanins; Cell Adhesion; Cell Movement; Cell Survival; Electrophoretic Mobility Shift Assay; Glucosides; HeLa Cells; Humans; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; NF-kappa B; Oryza; Specific Pathogen-Free Organisms; Transcription Factor AP-1; Urokinase-Type Plasminogen Activator | 2006 |
Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography.
Topics: Animals; Autoradiography; Cell Hypoxia; Female; Fluorine Radioisotopes; Glucosides; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iodine Radioisotopes; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Nitroimidazoles; Oligopeptides; Radionuclide Imaging | 2008 |
Novel indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11-dihydroxy- 13-(beta-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo-[3,4-c]carbazole- 5,7(6H)-dione (NB-506): its potent antitumor activities in mice.
Topics: Animals; Antineoplastic Agents; Carbazoles; Female; Glucosides; Humans; Lethal Dose 50; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Tumor Cells, Cultured | 1995 |
ED-110, a novel indolocarbazole, prevents the growth of experimental tumors in mice.
Topics: Animals; Antineoplastic Agents; Carbazoles; Female; Fibrosarcoma; Glucosides; Humans; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Stomach Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 1993 |
Assessment of the carcinogenicity of stevioside in F344 rats.
Topics: Administration, Oral; Animals; Body Weight; Carcinogenicity Tests; Diterpenes; Diterpenes, Kaurane; Eating; Female; Glucosides; Kidney Diseases; Male; Neoplasms, Experimental; Organ Size; Rats; Rats, Inbred F344; Survival Rate; Sweetening Agents; Terpenes | 1997 |
Synthesis and biological activities of topoisomerase I inhibitors, 6-N-amino analogues of NB-506.
Topics: Animals; Antineoplastic Agents; Carbazoles; DNA Topoisomerases, Type I; Enzyme Inhibitors; Glucosides; Humans; Indoles; Inhibitory Concentration 50; Kinetics; Mice; Models, Chemical; Neoplasms, Experimental; Pyrroles; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1999 |
Lack of carcinogenicity of gardenia blue colour given chronically in the diet to F344 rats.
Topics: Administration, Oral; Animals; Blood; Body Weight; Carcinogenicity Tests; Dose-Response Relationship, Drug; Female; Glucosides; Iridoids; Male; Neoplasms, Experimental; Organ Size; Plant Extracts; Pyrans; Rats; Rats, Inbred F344; Survival Rate | 2000 |
Antitumour and immunosuppressive activity of hydroxyanthraquinones and their glucosides.
Topics: Animals; Anthraquinones; Glucosides; Glycosides; Graft Survival; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Neoplasms, Experimental | 1977 |
Chronic oral toxicity and carcinogenicity study of stevioside in rats.
Topics: Animals; Body Weight; Carcinogens; Diterpenes; Diterpenes, Kaurane; Eating; Female; Glucosides; Lung; Male; Neoplasms, Experimental; Organ Size; Rats; Rats, Wistar; Sweetening Agents; Terpenes; Time Factors | 1992 |